You are here

Pharmaceutical Approval Update July 2009

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics include iloperidone (Fanapt) for the acute treatment of schizophrenia; bromocriptine mesylate tablets (Cycloset) for glycemic control in type-2 diabetes; and tolvaptan (Samsca) for patients with hyponatremia.